Sign in

CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
813909017
Phone
(510) 871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 8-K Event Results of operations
  9. 10-K Report Annual Report
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Insider Changes in Ownership
  14. 8-K Event Bylaws or fiscal year change
  15. 424B4 Offering Prospectus
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  18. EFFECT Other Notice of Effectiveness
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 6 of 8 · 156 filings